Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### International Trade Commission

          - [Investigation Nos. 701-TA-737-738 and 731-TA-1712-1715 (Preliminary)]

## Determinations

                    On the basis of the record [1]                                          developed in the subject investigations, the United States International Trade Commission (“Commission”) determines, pursuant to the Tariff Act of 1930 (“the Act”), that there is a reasonable indication that an industry in the United States is materially injured by reason of imports of hexamine (hexamethylenetetramine) from China, Germany, India, and Saudi Arabia, provided for in subheading 2933.69.50 of the Harmonized Tariff Schedule of the United States, that are alleged to be sold in the United States at less than fair value (“LTFV”) and imports of the subject merchandise from China and India that are alleged to be subsidized by the governments of China and India.[2 3] 

## Commencement of Final Phase Investigations

                    Pursuant to section 207.18 of the Commission's rules, the Commission also gives notice of the commencement of the final phase of its investigations. The Commission will issue a final phase notice of scheduling, which will be published in the                     **Federal Register**                     as provided in § 207.21 of the Commission's rules, upon notice from the U.S. Department of Commerce (“Commerce”) of affirmative preliminary determinations in the investigations under §§ 703(b) or 733(b) of the Act, or, if the preliminary determinations are negative, upon notice of affirmative final determinations in those investigations under §§ 705(a) or 735(a) of the Act. Parties that filed entries of appearance in the preliminary phase of the investigations need not enter a separate appearance for the final phase of the investigations. Any other party may file an entry of appearance for the final phase of the investigations after publication of the final phase notice of scheduling. Industrial users, and, if the merchandise under investigation is sold at the retail level, representative consumer organizations have the right to appear as parties in Commission antidumping and countervailing duty investigations. The Secretary will prepare a public service list containing the names and addresses of all persons, or their representatives, who are parties to the investigations. As provided in section 207.20 of the Commission's rules, the Director of the Office of Investigations will circulate draft questionnaires for the final phase of the investigations to parties to the investigations, placing copies on the Commission's Electronic Document Information System (EDIS,                     *https://edis.usitc.gov*), for comment.                

## Background

On September 30, 2024, Bakelite Synthetics (Atlanta, Georgia) filed petitions with the Commission and Commerce, alleging that an industry in the United States is materially injured or threatened with material injury by reason of subsidized imports of hexamine from China and India and LTFV imports of hexamine from China, Germany, India, and Saudi Arabia. Accordingly, effective September 30, 2024, the Commission instituted countervailing duty investigation Nos. 701-TA-737-738 and antidumping duty investigation Nos. 731-TA-1712-1715 (Preliminary).

                    Notice of the institution of the Commission's investigations and of a public conference to be held in connection therewith was given by posting copies of the notice in the Office of the Secretary, U.S. International Trade Commission, Washington, DC, and by publishing the notice in the                     **Federal Register**                     on October 4, 2024 (89 FR 80929). The Commission conducted its conference on October 21, 2024. All persons who requested the opportunity were permitted to participate.                

                    The Commission made these determinations pursuant to §§ 703(a) and 733(a) of the Act (19 U.S.C. 1671b(a) and 1673b(a)). It completed and filed its determinations in these investigations on November 14, 2024. The views of the Commission are contained in USITC Publication 5563 (November 2024), entitled                     *Hexamine (Hexamethylenetetramine) from China, Germany, India, and Saudi Arabia: Investigation Nos. 701-TA-737-738 and 731-TA-1712-1715 (Preliminary).*

By order of the Commission.

Issued: November 14, 2024.

Sharon Bellamy,

Supervisory Hearings and Information Officer.

# Footnotes

1.                             The record is defined in § 207.2(f) of the Commission's Rules of Practice and Procedure (19 CFR 207.2(f)).                    
        Back to Citation      

2.                             89 FR 87545 and 87560 (November 4, 2024).                    

3.                             Chair Karpel determines that there is a reasonable indication that an industry in the United States is threatened with material injury by reason of imports of hexamine from China, Germany, India, and Saudi Arabia that are alleged to be sold in the United States at LTFV and imports of the subject merchandise from China and India that are alleged to be subsidized by the governments of China and India.                    
        Back to Citation      

[FR Doc. 2024-26998 Filed 11-19-24; 8:45 am]

BILLING CODE 7020-02-P